Pharma redoubles effort against 10 neglected tropical diseases

A group of major pharmaceutical companies are carrying out a commitment to control or eliminate the 10 neglected tropical diseases (NTD) responsible for 90% of the global NTD burden.

The goal is part of the London Declaration, a coordinated effort by more than 20 major pharmaceutical companies and non-profit bodies to combat diseases affecting up to 1.5 billion people, primarily in developing countries.

Six of those companies are now working with charitable research group Drugs for Neglected Diseases initiative (DNDi), in a new collaboration to make good on that promise.